세계의 특수 의약품 시장 보고서(2025년)

Specialty pharmaceuticals refer to a category of medications that are high-cost, complex, and often require special handling, administration, or monitoring. These drugs are primarily used to treat chronic, rare, or complex conditions such as cancer, autoimmune diseases, and rare genetic disorders.

The primary drug types of specialty pharmaceuticals include biologics, biosimilars, orphan drugs, small molecules, and others. Biologics are complex medicines derived from living organisms or their components, used to treat various diseases. The routes of administration include oral, injectable, intranasal, transdermal, and inhalation, covering therapeutic areas such as oncology, autoimmune diseases, neurology, infectious diseases, rare genetic disorders, and more. Distribution channels encompass both online and offline platforms, with key end users being hospitals, specialty clinics, homecare settings, and pharmacies.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The specialty pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides specialty pharmaceuticals market statistics, including the specialty pharmaceuticals industry global market size, regional shares, competitors with the specialty pharmaceuticals market share, detailed specialty pharmaceuticals market segments, market trends, and opportunities, and any further data you may need to thrive in the specialty pharmaceuticals industry. This specialty pharmaceuticals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The specialty pharmaceuticals market size has grown rapidly in recent years. It will grow from $540.10 billion in 2024 to $594.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth observed during the historic period can be attributed to rising demand for targeted therapies, an increasing prevalence of chronic diseases, a surge in biopharmaceutical innovations, a rise in specialty drug approvals, and growing healthcare expenditure.

The specialty pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to$861.18 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to the increasing adoption of personalized medicine, rising investments in biologics and biosimilars, a growing prevalence of rare diseases, expanding healthcare infrastructure in emerging markets, and an increasing focus on specialty drug pipeline development. Major trends expected in this period include advancements in biologics and gene therapies, advanced drug delivery technologies, innovations in personalized medicine, integration of digital health and AI, and progress in biosimilar development.

The rising prevalence of chronic diseases is expected to drive growth in the specialty pharmaceuticals market moving forward. Chronic diseases are long-term health conditions that usually last a year or more, requiring ongoing medical care or limiting daily activities. This increase is largely attributed to the aging population, as older individuals are more prone to conditions like diabetes, heart disease, and arthritis. Specialty pharmaceuticals assist in managing chronic diseases by offering targeted, highly effective treatments that improve patient outcomes and quality of life, especially when standard therapies fall short. For example, in June 2024, the National Library of Medicine, a US-based medical library, reported that the number of Americans aged 50 and above living with at least one chronic condition is expected to nearly double by 2050, reaching about 142.66 million, a remarkable 99.5% rise. Consequently, the growing prevalence of chronic diseases is fueling the expansion of the specialty pharmaceuticals market.

Leading companies in the specialty pharmaceuticals market are concentrating on developing innovative solutions like integrated digital care spaces to boost patient engagement, enhance treatment adherence, and optimize care delivery. Integrated digital care spaces are either virtual or physical environments equipped with digital health technologies that facilitate coordinated remote and in-person care by connecting patients, healthcare providers, and support services, ultimately improving treatment outcomes and efficiency. For instance, in April 2024, Walgreens Boots Alliance, Inc., a US-based pharmacy-led health and wellness company, launched gene and cell therapy services within its newly integrated specialty pharmacy division. This initiative focuses on advanced gene and cell therapies, aiming to enhance patient care and treatment management. The facility supports the complex logistics and specialized requirements of these advanced therapies, demonstrating Walgreens' dedication to expanding its presence in the specialty pharmaceuticals sector.

In October 2022, Pfizer Inc., a US-based pharmaceutical company, acquired Biohaven Pharmaceuticals for $11.6 billion. This acquisition allows Pfizer to strengthen its neurology portfolio by obtaining full global rights to Biohaven's migraine medication Nurtec ODT and its innovative CGRP-based pipeline. Biohaven Pharmaceuticals Inc., also US-based, specializes in developing treatments for rare neurological and immunological disorders.

Major players in the specialty pharmaceuticals market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., GlaxoSmithKline plc, Gilead Sciences Inc., Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Apotex Inc., Cipla Limited, Hikma Pharmaceuticals plc, United Therapeutics Corporation, Mallinckrodt plc, Biocon Biologics Limited, Medicure Inc.

North America was the largest region in the specialty pharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in specialty pharmaceuticals report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the specialty pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The specialty pharmaceuticals market consists of sales of personalized medicine, rare disease treatments, and cellular immunotherapies. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Specialty Pharmaceuticals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on specialty pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for specialty pharmaceuticals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The specialty pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Types: Biologics; Biosimilars; Orphan Drugs; Small Molecules; Other Drug Types
• 2) By Route Of Administration: Oral; Injectables; Intranasal; Transdermal; Inhalation
• 3) By Therapeutic Area: Oncology; Autoimmune Diseases; Neurology; Infectious Diseases; Rare Genetic Disorders; Other Therapeutic Areas
• 4) By Distribution Channel: Online; Offline
• 5) By End User: Hospitals; Specialty Clinics; Homecare Settings; Pharmacies
• Subsegments:
• 1) By Biologics: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Cell And Gene Therapies; Fusion Proteins
• 2) By Biosimilars: Monoclonal Antibody Biosimilars; Insulin Biosimilars; Growth Hormone Biosimilars; Erythropoietin Biosimilars; Other Biosimilars
• 3) By Orphan Drugs: Rare Genetic Disorders; Rare Cancers; Rare Metabolic Disorders; Rare Infectious Diseases; Rare Autoimmune Diseases
• 4) By Small Molecules: Chemotherapy Agents; Immunosuppressants; Anti-inflammatory Agents; Antiviral Drugs; Hormonal Therapies
• 5) By Other Drug Types: Advanced Drug Delivery Systems; Combination Therapies; Personalized Medicines; Nanomedicines; Radiopharmaceuticals
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.; GlaxoSmithKline plc; Gilead Sciences Inc.; Amgen Inc.; Viatris Inc.; Teva Pharmaceutical Industries Limited; Bausch Health Companies Inc.; Sun Pharmaceutical Industries Limited; Apotex Inc.; Cipla Limited; Hikma Pharmaceuticals plc; United Therapeutics Corporation; Mallinckrodt plc; Biocon Biologics Limited; Medicure Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Specialty Pharmaceuticals Market Characteristics

3. Specialty Pharmaceuticals Market Trends And Strategies

4. Specialty Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Specialty Pharmaceuticals Growth Analysis And Strategic Analysis Framework

• 5.1. Global Specialty Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Specialty Pharmaceuticals Market Growth Rate Analysis
• 5.4. Global Specialty Pharmaceuticals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Specialty Pharmaceuticals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Specialty Pharmaceuticals Total Addressable Market (TAM)

6. Specialty Pharmaceuticals Market Segmentation

• 6.1. Global Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biologics
• Biosimilars
• Orphan Drugs
• Small Molecules
• Other Drug Types
• 6.2. Global Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectables
• Intranasal
• Transdermal
• Inhalation
• 6.3. Global Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Autoimmune Diseases
• Neurology
• Infectious Diseases
• Rare Genetic Disorders
• Other Therapeutic Areas
• 6.4. Global Specialty Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.5. Global Specialty Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Speciality Clinics
• Homecare Settings
• Pharmacies
• 6.6. Global Specialty Pharmaceuticals Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibodies
• Recombinant Proteins
• Vaccines
• Cell And Gene Therapies
• Fusion Proteins
• 6.7. Global Specialty Pharmaceuticals Market, Sub-Segmentation Of Biosimilars, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monoclonal Antibody Biosimilars
• Insulin Biosimilars
• Growth Hormone Biosimilars
• Erythropoietin Biosimilars
• Other Biosimilars
• 6.8. Global Specialty Pharmaceuticals Market, Sub-Segmentation Of Orphan Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rare Genetic Disorders
• Rare Cancers
• Rare Metabolic Disorders
• Rare Infectious Diseases
• Rare Autoimmune Diseases
• 6.9. Global Specialty Pharmaceuticals Market, Sub-Segmentation Of Small Molecules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy Agents
• Immunosuppressants
• Anti-inflammatory Agents
• Antiviral Drugs
• Hormonal Therapies
• 6.10. Global Specialty Pharmaceuticals Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Advanced Drug Delivery Systems
• Combination Therapies
• Personalized Medicines
• Nanomedicines
• Radiopharmaceuticals

7. Specialty Pharmaceuticals Market Regional And Country Analysis

• 7.1. Global Specialty Pharmaceuticals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Specialty Pharmaceuticals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Specialty Pharmaceuticals Market

• 8.1. Asia-Pacific Specialty Pharmaceuticals Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Specialty Pharmaceuticals Market

• 9.1. China Specialty Pharmaceuticals Market Overview
• 9.2. China Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Specialty Pharmaceuticals Market

• 10.1. India Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Specialty Pharmaceuticals Market

• 11.1. Japan Specialty Pharmaceuticals Market Overview
• 11.2. Japan Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Specialty Pharmaceuticals Market

• 12.1. Australia Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Specialty Pharmaceuticals Market

• 13.1. Indonesia Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Specialty Pharmaceuticals Market

• 14.1. South Korea Specialty Pharmaceuticals Market Overview
• 14.2. South Korea Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Specialty Pharmaceuticals Market

• 15.1. Western Europe Specialty Pharmaceuticals Market Overview
• 15.2. Western Europe Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Specialty Pharmaceuticals Market

• 16.1. UK Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Specialty Pharmaceuticals Market

• 17.1. Germany Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Specialty Pharmaceuticals Market

• 18.1. France Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Specialty Pharmaceuticals Market

• 19.1. Italy Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Specialty Pharmaceuticals Market

• 20.1. Spain Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Specialty Pharmaceuticals Market

• 21.1. Eastern Europe Specialty Pharmaceuticals Market Overview
• 21.2. Eastern Europe Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Specialty Pharmaceuticals Market

• 22.1. Russia Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Specialty Pharmaceuticals Market

• 23.1. North America Specialty Pharmaceuticals Market Overview
• 23.2. North America Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Specialty Pharmaceuticals Market

• 24.1. USA Specialty Pharmaceuticals Market Overview
• 24.2. USA Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Specialty Pharmaceuticals Market

• 25.1. Canada Specialty Pharmaceuticals Market Overview
• 25.2. Canada Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Specialty Pharmaceuticals Market

• 26.1. South America Specialty Pharmaceuticals Market Overview
• 26.2. South America Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Specialty Pharmaceuticals Market

• 27.1. Brazil Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Specialty Pharmaceuticals Market

• 28.1. Middle East Specialty Pharmaceuticals Market Overview
• 28.2. Middle East Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Specialty Pharmaceuticals Market

• 29.1. Africa Specialty Pharmaceuticals Market Overview
• 29.2. Africa Specialty Pharmaceuticals Market, Segmentation By Drug Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Specialty Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Specialty Pharmaceuticals Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Specialty Pharmaceuticals Market Competitive Landscape And Company Profiles

• 30.1. Specialty Pharmaceuticals Market Competitive Landscape
• 30.2. Specialty Pharmaceuticals Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Specialty Pharmaceuticals Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. GlaxoSmithKline plc
• 31.3. Gilead Sciences Inc.
• 31.4. Amgen Inc.
• 31.5. Viatris Inc.
• 31.6. Teva Pharmaceutical Industries Limited
• 31.7. Bausch Health Companies Inc.
• 31.8. Sun Pharmaceutical Industries Limited
• 31.9. Apotex Inc.
• 31.10. Cipla Limited
• 31.11. Hikma Pharmaceuticals plc
• 31.12. United Therapeutics Corporation
• 31.13. Mallinckrodt plc
• 31.14. Biocon Biologics Limited
• 31.15. Medicure Inc.

32. Global Specialty Pharmaceuticals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Specialty Pharmaceuticals Market

34. Recent Developments In The Specialty Pharmaceuticals Market

35. Specialty Pharmaceuticals Market High Potential Countries, Segments and Strategies

• 35.1 Specialty Pharmaceuticals Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Specialty Pharmaceuticals Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Specialty Pharmaceuticals Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer